The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Discussion on the latest research for using bisphosphonates to treat cancer metastasis

NCRI

Published: 10 Nov 2009

Views: 12071

Rating:

Save

Professor Robert Coleman - Cancer Research Centre, Academic Unit of Clinical Oncology, Weston Park Hospital

Categories:
Biology

Related Videos

Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly wit...

Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain

$Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma ( Dr Anna Sureda - Blood Cell Barcelona Hematology Institute, Barcelona, Spain )$

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and...

Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer ( Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey )

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphom...

Dr Carol Moreno - University of Barcelona, Barcelona, Spain

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS ( Dr Carol Moreno - University of Barcelona, Barcelona, Spain )

Rucaparib effective as maintenance therapy following first-line platinum-based c...

Dr Bradley Monk - University of Arizona College, Tucson, USA

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer ( Dr Bradley Monk - University of Arizona College, Tucson, USA )

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advan...

Dr Yohann Loriot - Institut Gustave Roussy, Villejuif, France

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies ( Dr Yohann Loriot - Institut Gustave Roussy, Villejuif, France )

ASCO 2022: The latest in RCC

Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri

ASCO 2022: The latest in RCC ( Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri )

Efficacy and safety of ARI0002H, a BCMA-directed CAR-T cell therapy with fractio...

Dr Carlos Fernández De Larrea - Hospital Clínic de Barcelona, Spain

$Efficacy and safety of ARI0002H, a BCMA-directed CAR-T cell therapy with fractionated initial therapy and booster dose in RRMM ( Dr Carlos Fernández De Larrea - Hospital Clínic de Barcelona, Spain )$

Safety and efficacy of the bispecific antibody talquetamab in relapsed/refractor...

Prof Monique Minnema - University Medical Center Utrecht, Utrecht, Netherlands

$Safety and efficacy of the bispecific antibody talquetamab in relapsed/refractory multiple myeloma ( Prof Monique Minnema - University Medical Center Utrecht, Utrecht, Netherlands )$

Ponatinib and blinatumomab for patients with Philadelphia chromosome-positive AL...

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA

Ponatinib and blinatumomab for patients with Philadelphia chromosome-positive ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )

More from ecancer